DexCom, Inc. (DXCM) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-11 (expected, after the close). EPS estimate 0.71, revenue estimate 1.38B.
Over the last 12 reports the stock moved 10.7% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | 0.73 | 0.68 | +8.1% | 1.34B | 1.33B | +4.7% |
| Q2 FY2026 | 2026-07-30 | 0.70 | 0.61 | +14.6% | 1.31B | 1.29B | +11.1% |
| Q1 FY2026 | 2026-04-30 | 0.56 | 0.47 | +20.3% | 1.19B | 1.17B | +6.6% |
| Q4 FY2025 | 2026-02-12 | 0.68 | 0.65 | +4.6% | 1.26B | 1.25B | +2.7% |
| Q3 FY2025 | 2025-10-30 | 0.61 | 0.58 | +5.9% | 1.21B | 1.18B | -14.6% |
| Q2 FY2025 | 2025-07-30 | 0.48 | 0.44 | +8.2% | 1.16B | 1.12B | -9.6% |
| Q1 FY2025 | 2025-05-01 | 0.32 | 0.33 | -2.2% | 1.04B | 1.02B | +14.3% |
| Q4 FY2024 | 2025-02-13 | 0.45 | 0.48 | -6.1% | 1.11B | 1.11B | +6.2% |